2m 2m 2m 2m 2m 2m 2m
Belite Bio Sp ADR (BLTE)
NASDAQ
$150.50+$0.23 (+0.15%)
Price as of Oct 22, 2026 7:37 PM EDT- $6.2BMarket Cap
- 62.95%1-Year Change
- BiotechnologyIndustry
Belite Bio Sp ADR (BLTE)
$150.50+$0.23 (+0.15%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
DARWIN GLOBAL MANAGEMENT, LTD. | 7.64% | 3.1M | +19,807 (+0.64%) | Jun 30, 2026 |
PARADIGM BIOCAPITAL ADVISORS LP | 3.06% | 1.2M | +118,093 (+9.58%) | Jun 30, 2026 |
RTW INVESTMENTS, LP | 1.78% | 715,332 | 0 (0.00%) | Jun 30, 2026 |
MILLENNIUM MANAGEMENT LLC | 1.23% | 494,564 | -75,524 (-15.27%) | Jun 30, 2026 |
MAVERICK CAPITAL LTD | 0.98% | 396,311 | +396,311 (+100.00%) | Jun 30, 2026 |
EVENTIDE ASSET MANAGEMENT, LLC | 0.97% | 390,829 | +33,179 (+8.49%) | Jun 30, 2026 |
DEERFIELD MANAGEMENT COMPANY, L.P. | 0.89% | 357,199 | +53,186 (+14.89%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
T. Rowe Price Health Sciences Fund, Inc. | 0.20% | 80,462 | -127,400 (-158.34%) | Jun 30, 2026 |
MUTUAL FUND SERIES TRUST | 0.15% | 62,205 | +33,179 (+53.34%) | Jun 30, 2026 |
SPDR INDEX SHARES FUNDS | 0.04% | 15,524 | -124 (-0.80%) | Jun 30, 2026 |
FIDELITY CONCORD STREET TRUST | 0.01% | 5,934 | -793 (-13.36%) | Jul 31, 2026 |
T. Rowe Price Equity Series, Inc. | 0.01% | 5,400 | -7,300 (-135.19%) | Jun 30, 2026 |
TRUST FOR PROFESSIONAL MANAGERS | 0.01% | 4,158 | +445 (+10.70%) | Aug 31, 2026 |
FIDELITY COMMONWEALTH TRUST | 0.009% | 3,734 | +37 (+0.99%) | May 31, 2026 |
Current Ownership Distribution
- Institutions32.5M (80.59%)
- Other6.4M (15.80%)
- Mutual Funds1.2M (2.90%)
- Insiders284,030 (0.71%)
Insider Transactions
- 0.71% (284,030)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 3Number of InsiderSelling (last 12 months)
- $647.3MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Scholl Hendrik Peter Chief Medical Officer | Sell | Oct 01, 2026 | $32,725.00 | 200 | $163.63 | 14,800 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Oct 01, 2026 | $3,951.38 | 24 | $164.64 | 14,776 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Oct 01, 2026 | $19,859.22 | 120 | $165.49 | 14,656 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Oct 01, 2026 | $8,321.84 | 50 | $166.44 | 14,606 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Oct 01, 2026 | $13,071.83 | 78 | $167.59 | 14,528 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Oct 01, 2026 | $2,018.54 | 12 | $168.21 | 14,516 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Oct 01, 2026 | $2,371.04 | 14 | $169.36 | 14,502 |
Scholl Hendrik Peter Chief Medical Officer | Sell | Oct 01, 2026 | $340.04 | 2 | $170.02 | 14,500 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 08, 2026 | $466,398.72 | 2,400 | $194.33 | 93,734 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 08, 2026 | $427,414.02 | 2,200 | $194.28 | 41,800 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 08, 2026 | $1.2M | 6,090 | $195.62 | 87,644 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 08, 2026 | $805,888.89 | 4,120 | $195.60 | 37,680 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 08, 2026 | $1.2M | 6,058 | $196.54 | 81,586 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 08, 2026 | $879,199.67 | 4,475 | $196.47 | 33,205 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 08, 2026 | $1.7M | 8,752 | $197.36 | 72,834 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 08, 2026 | $908,243.69 | 4,605 | $197.23 | 28,600 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 08, 2026 | $534,844.89 | 2,700 | $198.09 | 70,134 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 08, 2026 | $507,392.31 | 2,562 | $198.05 | 26,038 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 04, 2026 | $475,071.26 | 2,635 | $180.29 | 167,934 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 04, 2026 | $294,200.79 | 1,633 | $180.16 | 91,800 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 04, 2026 | $468,876.68 | 2,587 | $181.24 | 165,347 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 04, 2026 | $362,106.60 | 2,000 | $181.05 | 89,800 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 04, 2026 | $622,869.09 | 3,413 | $182.50 | 161,934 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 04, 2026 | $364,985.20 | 2,000 | $182.49 | 87,800 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 04, 2026 | $908,228.21 | 4,955 | $183.30 | 156,979 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 04, 2026 | $688,899.15 | 3,759 | $183.27 | 84,041 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 04, 2026 | $1.2M | 6,252 | $184.52 | 150,727 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 04, 2026 | $658,743.54 | 3,569 | $184.57 | 80,472 |
Lin Yu-Hsin Chief Executive Officer | Sell | Sep 04, 2026 | $851,286.37 | 4,593 | $185.34 | 146,134 |
Chuang Hao-Yuan Chief Financial Officer | Sell | Sep 04, 2026 | $717,407.64 | 3,872 | $185.28 | 76,600 |